Ecovyst vs Perimeter
ECVT and PRM side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ECVT and PRM compare
Perimeter is the larger company, worth 4.2 times as much as Ecovyst ($5.0B against $1.2B).
On earnings, Ecovyst is cheaper: it trades at 33.8× trailing earnings, against 170× for Perimeter.
Ecovyst grew revenue faster over the last twelve months (44.6% versus 30.7% for Perimeter).
Perimeter keeps more of each dollar of sales as profit, with a net margin of 6.7% compared with 3.7% at Ecovyst.
Ecovyst scores higher on the StockData Score (9 against 7 for Perimeter), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ECVT | PRM |
|---|---|---|
| Size and price | ||
| Market cap | $1.2B | $5.0B |
| Share price | $10.82 | $30.67 |
| Change, 1 year | 26.1% | 19.7% |
| Change, 5 years | 11.4% | 138% |
| Beta (5Y) | 0.85 | 1.22 |
| Employees | 617 | 356 |
| StockData Score | ||
| Total score | 9 (better) | 7 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 3 | 3 |
| Health score | 3 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 33.8× (better) | 170× |
| P/S | 1.2× (better) | 6.0× |
| P/B | 2.0× (better) | 3.8× |
| EV/EBITDA | 19.4× (better) | 26.9× |
| P/FCF | 44.2× (better) | 93.1× |
| FCF yield | 2.3% (better) | 1.1% |
| Fair value | $7.22 | $9.21 |
| Margin of safety | −49.9% (better) | −233% |
| Growth | ||
| Revenue growth (TTM) | 44.6% (better) | 30.7% |
| Revenue growth, 5Y average | 7.8% | 14.0% (better) |
| Net income growth (TTM) | – | −28.8% |
| EPS growth (TTM) | – | −64.0% |
| Profitability | ||
| Gross margin | 19.7% | 54.5% (better) |
| Operating margin | 8.5% | 14.5% (better) |
| Net margin | 3.7% | 6.7% (better) |
| FCF margin | 2.8% | 6.5% (better) |
| Return on equity | 5.9% (better) | 4.6% |
| Return on invested capital | 5.4% | 6.3% (better) |
| Financial health | ||
| Debt / equity | 0.81 (better) | 0.91 |
| Net debt / EBITDA | 5.09 | 4.82 (better) |
| Interest coverage | 3.8× (better) | 1.6× |
| Current ratio | 1.82 | 2.79 (better) |
| Altman Z-score | 1.63 | 1.70 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 4.9% (better) | 0.00% |
| Shareholder yield | 4.9% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 100% | 85.6% |
| Held by insiders | 2.5% | 22.6% |
| Insider net buying, 12 months | $137K (better) | −$435M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 6.2% | 5.2% |
Go deeper
- ECVT stock overview
- ECVT income statement
- ECVT valuation and score
- PRM stock overview
- PRM income statement
- PRM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.